LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,189,000 | +6.7% | 30,068 | +0.5% | 0.01% | 0.0% |
| Q2 2021 | $3,925,000 | -10.7% | 29,921 | +3.8% | 0.01% | -16.7% |
| Q1 2021 | $4,395,000 | -34.7% | 28,826 | -57.4% | 0.01% | -33.3% |
| Q4 2020 | $6,727,000 | +81.9% | 67,644 | +74.3% | 0.02% | +38.5% |
| Q3 2020 | $3,699,000 | -9.1% | 38,807 | +6.7% | 0.01% | -18.8% |
| Q2 2020 | $4,069,000 | +67.4% | 36,383 | +8.8% | 0.02% | +23.1% |
| Q1 2020 | $2,431,000 | -2.3% | 33,426 | +40.2% | 0.01% | 0.0% |
| Q4 2019 | $2,487,000 | +328.8% | 23,847 | +309.0% | 0.01% | +333.3% |
| Q3 2019 | $580,000 | -12.9% | 5,831 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $666,000 | +85.5% | 5,831 | +104.3% | 0.00% | +100.0% |
| Q1 2019 | $359,000 | – | 2,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |